Iron metabolism and the IRIE/IRP regulatory system - An update

被引:390
作者
Pantopoulos, K
机构
[1] Sir Mortimer B Davis Jewish Hosp, Lady Davis Inst Med Res, Montreal, PQ H3T 1E2, Canada
[2] McGill Univ, Dept Med, Montreal, PQ, Canada
来源
REDOX-ACTIVE METALS IN NEUROLOGICAL DISORDERS | 2004年 / 1012卷
关键词
iron metabolism; ferritin; transferrin receptor; iron responsive elements; IRP1; IRP2; oxidative stress; aconitase; DMT1; ferroportin;
D O I
10.1196/annals.1306.001
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Cellular iron homeostasis is accomplished by the coordinated regulated expression of the transferrin receptor and ferritin, which mediate iron uptake and storage, respectively. The mechanism is posttranscriptional and involves two cytoplasmic iron regulatory proteins, IRP1 and IRP2. Under conditions of iron starvation, IRPs stabilize the transferrin receptor and inhibit the translation of ferritin mRNAs by binding to "iron responsive elements" (IREs) within their untranslated regions. The IRE/IRP system also controls the expression of additional IRE-containing mRNAs, encoding proteins of iron and energy metabolism. The activities of IRP1 and IRP2 are regulated by distinct posttranslational mechanisms in response to cellular iron levels. Thus, in iron-replete cells, IRP1 assembles a cubane iron-sulfur cluster, which prevents IRE binding, while IRP2 undergoes proteasomal degradation. IRP1 and IRP2 also respond, albeit differentially, to iron-independent signals, such as hydrogen peroxide, hypoxia, or nitric oxide. Basic principles of the IRE/IRP system and recent advances in understanding the regulation and the function of IRP1 and IRP2 are discussed.
引用
收藏
页码:1 / 13
页数:13
相关论文
共 76 条
[1]   Iron metabolism [J].
Aisen, P ;
Wessling-Resnick, M ;
Leibold, EA .
CURRENT OPINION IN CHEMICAL BIOLOGY, 1999, 3 (02) :200-206
[2]   Chemistry and biology of eukaryotic iron metabolism [J].
Aisen, P ;
Enns, C ;
Wessling-Resnick, M .
INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY, 2001, 33 (10) :940-959
[3]   Iron homeostasis: Insights from genetics and animal models [J].
Andrews, NC .
NATURE REVIEWS GENETICS, 2000, 1 (03) :208-217
[4]   Medical progress: Disorders of iron metabolism [J].
Andrews, NC .
NEW ENGLAND JOURNAL OF MEDICINE, 1999, 341 (26) :1986-1995
[5]   Brain iron pathways and their relevance to Parkinson's disease [J].
Berg, D ;
Gerlach, M ;
Youdim, MBH ;
Double, KL ;
Zecca, L ;
Riederer, P ;
Becker, G .
JOURNAL OF NEUROCHEMISTRY, 2001, 79 (02) :225-236
[6]   Iron: A pathological mediator of Alzheimer disease? [J].
Bishop, GM ;
Robinson, SR ;
Liu, Q ;
Perry, G ;
Atwood, CS ;
Smith, MA .
DEVELOPMENTAL NEUROSCIENCE, 2002, 24 (2-3) :184-187
[7]   Structural changes associated with switching activities of human iron regulatory protein 1 [J].
Brazzolotto, X ;
Timmins, P ;
Dupont, Y ;
Moulis, JM .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2002, 277 (14) :11995-12000
[8]   Human cytoplasmic aconitase (iron regulatory protein 1) is converted into its [3Fe-4S] form by hydrogen peroxide in vitro but is not activated for iron-responsive element binding [J].
Brazzolotto, X ;
Gaillard, J ;
Pantopoulos, K ;
Hentze, MW ;
Moulis, JM .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1999, 274 (31) :21625-21630
[9]   Novel role of phosphorylation in Fe-S cluster stability revealed by phosphomimetic mutations at Ser-138 of iron regulatory protein 1 [J].
Brown, NM ;
Anderson, SA ;
Steffen, DW ;
Carpenter, TB ;
Kennedy, MC ;
Walden, WE ;
Eisenstein, RS .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1998, 95 (26) :15235-15240
[10]   A conserved family of prolyl-4-hydroxylases that modify HIF [J].
Bruick, RK ;
McKnight, SL .
SCIENCE, 2001, 294 (5545) :1337-1340